Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 21, 2025 08:00 ET | Source: AskBio Inc. (AskBio)

AskBio Announces Publication in Nature Medicine of 12-month data from Phase 1 Trial of AB-1002 Gene Therapy in Participants with Congestive Heart Failure

Research Triangle Park, N.C., Oct. 21, 2025 (GLOBE NEWSWIRE) -- First-in-human trial of investigational gene therapy AB-1002 designed to evaluate safety and preliminary efficacy in participants...
October 10, 2025 08:00 ET | Source: AskBio Inc. (AskBio)

AskBio Presents Interim Safety Results from Phase 1/Phase 2 LION-CS101 Clinical Trial of AB-1003 in Participants with Limb-Girdle Muscular Dystrophy 2I/R9

Research Triangle Park, N.C., Oct. 10, 2025 (GLOBE NEWSWIRE) -- Data from first cohort of five participants suggest an acceptable safety profile for AB-1003 in participants with limb-girdle...
October 02, 2025 08:00 ET | Source: AskBio Inc. (AskBio)

AskBio Announces 6 Presentations at the European Society of Gene and Cell Therapy 32nd Annual Meeting

Research Triangle Park, N.C., Oct. 02, 2025 (GLOBE NEWSWIRE) --One oral presentation and five poster presentations will highlight exciting progress in AskBio’s pipeline and advancements in the...
September 30, 2025 07:00 ET | Source: Opus Genetics, Inc.

Opus Genetics Reports Positive Pediatric Data from OPGx-LCA5 Phase 1/2 Trial in Leber Congenital Amaurosis Type 5 (LCA5)

Opus Genetics Reports Positive Pediatric Data from OPGx-LCA5 Phase 1/2 Trial in Leber Congenital Amaurosis Type 5 (LCA5)
September 22, 2025 06:00 ET | Source: AskBio Inc. (AskBio)

First European Participants Randomized in AskBio Phase 2 Gene Therapy Trial of AB-1005 for Parkinson’s Disease

Research Triangle Park, N.C., Sept. 22, 2025 (GLOBE NEWSWIRE) -- AB-1005, a glial cell line-derived neurotrophic factor (GDNF) investigational gene therapy, is being evaluated for the treatment...
September 17, 2025 08:00 ET | Source: AskBio Inc. (AskBio)

AskBio Announces Completion of Enrollment in Phase 1 Clinical Trial of AB-1005 Gene Therapy for Multiple System Atrophy-Parkinsonian Type (MSA-P)

Research Triangle Park, N.C., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Final participant randomized to complete enrollment in Phase 1 clinical trial assessing safety of investigational gene therapy...
September 04, 2025 09:45 ET | Source: CMI

DNA Manufacturing Market to Hit USD 19.56 Billion by 2032 as Demand for Cell and Gene Therapies Continues to Rise

Burlingame, CA, Sept. 04, 2025 (GLOBE NEWSWIRE) -- The Global DNA Manufacturing Market is estimated to be valued at USD 6.44 Bn in 2025 and is expected to reach USD 19.56 Bn by 2032, exhibiting a...
May 27, 2025 08:51 ET | Source: AskBio Inc. (AskBio)

AskBio Announces Publication of Complete Results of Phase 1b Trial of AB-1005 Gene Therapy in Participants with Parkinson’s Disease in Movement Disorders

Research Triangle Park, N.C., May 27, 2025 (GLOBE NEWSWIRE) -- AB-1005 was well tolerated with no attributed serious adverse events in participants with mild or moderate Parkinson’s disease (PD)...
May 19, 2025 08:07 ET | Source: AskBio Inc. (AskBio)

AskBio Presents Complete Results of Phase 1 Trial of AB-1002 Gene Therapy in Participants with Congestive Heart Failure at European Society of Cardiology Heart Failure Meeting

Research Triangle Park, N.C., May 19, 2025 (GLOBE NEWSWIRE) --First-in-human trial of AB-1002 designed to evaluate safety and preliminary efficacy in participants with New York Heart Association...
May 08, 2025 08:00 ET | Source: Asklepios BioPharmaceutical, Inc. (AskBio)

AskBio Announces 15 Presentations at American Society of Gene and Cell Therapy 28th Annual Meeting

Research Triangle Park, N.C., May 08, 2025 (GLOBE NEWSWIRE) --Three oral and 12 poster presentations demonstrate breadth and progress of AskBio’s gene therapy research and development...